The 340B Drug Pricing Program is run by the Health Resources and Services Administration (HRSA), which is part of the Department of Health and Human Services (HHS). This program lets drug makers sell outpatient medicine at lower prices to eligible healthcare groups called “covered entities.” HRSA’s Office of Pharmacy Affairs (OPA) manages the program. They handle enrollment, eligibility checks, and make sure everyone follows the rules. Covered entities get a special 340B ID number that pharmacies use to confirm they can buy drugs at these lower prices.
Covered entities include certain hospitals and clinics that mainly serve low-income, rural, or uninsured people. The goal is to help these providers use their money better so they can offer more and better health services.
The 340B program says who can join under Section 340B(a)(4) of the Public Health Service Act. Only some types of healthcare groups that meet federal rules can join. The rules look at the kinds of patients they serve, their funding, and their hospital type. Covered entities must be federal grantees, non-profits, government-owned, or run by states. They must serve people who don’t get enough care. Here is a list of eligible groups:
These groups must have a real connection with the patients they help. This connection must fit with their grant or funding rules. This way, patients get the right benefits from the 340B drug discounts.
Covered entities must keep up-to-date paperwork to prove they qualify and to be ready for audits. They need to make sure federal grants or contracts are current. Hospitals must file Medicare Cost Reports every year. All records showing patient eligibility and following rules should be kept safe.
Each year, entities must confirm their eligibility again. They do this by updating their status in the 340B Office of Pharmacy Affairs Information System (OPAIS). They need to report any changes fast. If they lose eligibility, they must stop buying 340B drugs until it is fixed.
The documentation must include patient records like ID, health evaluations, and treatment history. In emergencies, HRSA allows shorter records or self-reported info to meet the rules.
Covered entities must sign up for the 340B program through the Office of Pharmacy Affairs Information System (OPAIS). They can only enroll during four periods each year: January 1-15, April 1-15, July 1-15, and October 1-15. Signing up outside these dates may delay when they can join.
The steps to enroll include:
During public health emergencies, HRSA may allow faster enrollment without waiting for the usual dates. This happened in states like Georgia and Texas to help people quickly.
The program covers most outpatient prescription drugs. These include brand-name, generic, and over-the-counter medicines used for both short-term and long-term illnesses. Some drugs are not included, like vaccines and some rare disease drugs. There can be exceptions depending on the type of covered entity.
Drugs should only be given to eligible patients. These patients must have a real relationship with the covered entity and received healthcare services under the funding program. Just giving a drug to someone for self-use without other care does not count as a 340B patient under HRSA rules.
Stopping misuse is important. Misuse includes giving drugs to people who don’t qualify (called medication diversion) or billing Medicaid twice for the same drug (called duplicate discounts). These mistakes can cause penalties, such as having to pay money back or losing program access.
HRSA checks the 340B program by auditing about 200 covered entities every year. They make sure the rules are followed, such as patient eligibility, correct drug prices, and proper reports. Entities must keep their info updated on the 340B OPAIS website and report any problems quickly.
Drug manufacturers also do audits but on a smaller scale and follow HRSA policies. If a covered entity breaks the rules, it may have to refund discounts, pay fines, or be removed from the program.
To avoid duplicate Medicaid discounts, covered entities must pick Medicaid billing options. They can either include 340B drugs in Medicaid claims with special billing codes (‘carve in’) or exclude these drugs from Medicaid billing (‘carve out’). Working closely with Medicaid programs and contract pharmacies is important.
Contract pharmacies help covered entities by filling 340B prescriptions. This widens access but makes following rules harder. Covered entities buy drugs at 340B prices, and contract pharmacies give them to patients. To keep rules, covered entities must:
Some states like Louisiana and Arkansas have made laws to protect contract pharmacy use in 340B. This shows there are ongoing challenges in managing the program.
Managing the 340B program is tough because of many rules and paperwork. Recently, artificial intelligence (AI) and automation tools help with this. AI can check patient eligibility by comparing records, insurance, and clinical data automatically. This lowers mistakes from manual work and helps make sure only qualified patients get discounted drugs.
AI systems can send alerts to track deadlines, spot pricing errors, detect risks of diversion or duplicate discounts, and help prepare for audits. These tools reduce human errors and speed up fixing compliance problems.
Automation tools can handle the quarterly enrollment process. They remind staff about deadlines, gather needed papers, and make sure forms meet HRSA rules. This lowers work for managers and lets them focus more on patient care.
AI software helps watch contract pharmacies by tracking prescriptions, managing audit trails, and checking billing. It helps covered entities keep control over many contract pharmacies and follow 340B rules, which is important with drug maker restrictions.
For admins and IT teams, AI and automation offer:
These features make running the 340B program easier, reduce costly mistakes, and help maximize savings.
Medical practice admins, owners, and IT managers should understand eligibility rules and registration steps well. They need to keep records ready for audits and look for technology to make following rules easier.
Because rules about contract pharmacies and drug makers change often, staying updated with HRSA news is important. Using AI tools can help groups keep access to discounted drugs, continue patient care, and avoid penalties for mistakes.
The 340B Drug Pricing Program was created in 1992 by Congress to provide safety-net providers discounts on outpatient drugs, enabling them to extend federal resources to provide more comprehensive services to vulnerable populations.
Eligible entities include various hospitals (e.g., disproportionate share hospitals, critical access hospitals) and non-hospital entities like federally qualified health centers, AIDS drug assistance programs, and more.
The program is administered by the Office of Pharmacy Affairs (OPA) within the Health Resources and Services Administration (HRSA) under HHS.
Entities can apply by completing the online registration process during the first two weeks of any calendar quarter, and approved entities are listed in the 340B OPA Information System.
Covered entities must decide whether to ‘carve in’ or ‘carve out’ 340B drugs for Medicaid fee-for-service patients, ensuring compliance with duplicate discount prohibitions to avoid overcharging.
Compliance is ensured through annual recertification, monitoring contract pharmacies, and establishing criteria for reporting breaches of compliance to HRSA.
Common pitfalls include improper billing practices, failure to monitor contract pharmacies, and inadequate documentation of patient eligibility.
Violating the ceiling price results in penalties, including refunding overcharges and potential civil monetary penalties for knowing violations.
Yes, covered entities can contract with pharmacies but must ensure compliance with 340B requirements, including tracking patient eligibility and preventing diversion.
HRSA conducts audits of covered entities, with approximately 200 audits per year, and manufacturers can also audit but must do so under specific HRSA guidelines.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
